Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Not Confirmed
Not Confirmed
27 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Webinar
Not Confirmed
27 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
https://www.prnewswire.com/news-releases/intron-development-of-phageria-anti-cancer-candidate-with-enhanced-antimicrobial-activity-by-robot-bacteriophage-platform-technology-302062490.html
30 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/intron-executes-evaluation-license-and-option-agreement-for-sal200-301972235.html
03 Sep 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/intron-signs-bacteriophage-development-project-with-us-army-devcom-301916586.html
29 May 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/intron-identifies-prophage-and-jamphage-in-the-pancreatic-cancer-related-microbiome-301836795.html
11 Jul 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/intron-confirms-efficacy-of-cdl200-against-cdi-clinical-isolates-301584277.html
06 Jun 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/intron-completes-glp-tox-studies-of-bal200-301549771.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?